ABCL
Price
$2.41
Change
-$0.08 (-3.21%)
Updated
May 2 closing price
Capitalization
719.2M
3 days until earnings call
RXRX
Price
$5.70
Change
+$0.20 (+3.64%)
Updated
May 2 closing price
Capitalization
2.32B
Earnings call today
Ad is loading...

ABCL vs RXRX

Header iconABCL vs RXRX Comparison
Open Charts ABCL vs RXRXBanner chart's image
AbCellera Biologics
Price$2.41
Change-$0.08 (-3.21%)
Volume$3.29M
Capitalization719.2M
Recursion Pharmaceuticals
Price$5.70
Change+$0.20 (+3.64%)
Volume$19.86M
Capitalization2.32B
ABCL vs RXRX Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. RXRX commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 05, 2025
Stock price -- (ABCL: $2.41 vs. RXRX: $5.70)
Brand notoriety: ABCL and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 79% vs. RXRX: 96%
Market capitalization -- ABCL: $719.2M vs. RXRX: $2.32B
ABCL [@Biotechnology] is valued at $719.2M. RXRX’s [@Biotechnology] market capitalization is $2.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 6 bearish.
  • RXRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -6.23% price change this week, while RXRX (@Biotechnology) price change was -0.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.32B) has a higher market cap than ABCL($719M). RXRX YTD gains are higher at: -15.680 vs. ABCL (-17.747). ABCL has higher annual earnings (EBITDA): -204.15M vs. RXRX (-426.72M). ABCL has more cash in the bank: 626M vs. RXRX (594M). ABCL has less debt than RXRX: ABCL (65.4M) vs RXRX (108M). RXRX has higher revenues than ABCL: RXRX (58.5M) vs ABCL (28.8M).
ABCLRXRXABCL / RXRX
Capitalization719M2.32B31%
EBITDA-204.15M-426.72M48%
Gain YTD-17.747-15.680113%
P/E RatioN/AN/A-
Revenue28.8M58.5M49%
Total Cash626M594M105%
Total Debt65.4M108M61%
TECHNICAL ANALYSIS
Technical Analysis
ABCLRXRX
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLLAX24.000.58
+2.48%
Principal SmallCap A
JIDVX11.450.21
+1.87%
Janus Henderson U.S. Dividend Income I
MICIX8.880.16
+1.83%
Victory Trivalent Intl Fd-Core Eq I
URLGX4.670.08
+1.74%
Columbia Select Large Cap Growth R
HGITX51.720.61
+1.19%
Hartford Core Equity R5

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-3.21%
CRSP - ABCL
62%
Loosely correlated
+1.38%
ABSI - ABCL
58%
Loosely correlated
N/A
NTLA - ABCL
58%
Loosely correlated
+2.31%
BEAM - ABCL
57%
Loosely correlated
+2.07%
RXRX - ABCL
56%
Loosely correlated
+3.64%
More